October 21 - ** Thermo Fisher Scientific (TMO.N) shares rose 1.13%, closing at $695.14
** The company reported third-quarter revenue of $12.14 billion, exceeding analysts' expectations of $11.95 billion—data compiled by LSEG
** Adjusted earnings per share for the third quarter were $6.68, beating the expected $6.40
** The company expects full-year revenue to be between $47.7 billion and $48.2 billion
** Full-year adjusted earnings per share are expected to range from $25.13 to $25.43
** Analysts expect full-year earnings per share of $25.14 and revenue of $47.8 billion
** Including today's price movement, the stock has risen 19% year-to-date
(To assist non-English native speakers, Reuters has automated the translation of its reports into several other languages. As automated translation may contain errors or lack required context, Reuters does not guarantee the accuracy of the automated translation text, which is provided solely for the convenience of readers. Reuters assumes no responsibility for any damages or losses arising from the use of the automated translation function.)